Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pfizer
Pharma
Eli Lilly is the ‘clear winner’ from ADA, RBC analyst says
Lilly emerged as the “clear winner from ADA,” said RBC's Trung Hyunh, who added “the field is getting more crowded—but Lilly is widening its lead.”
Kevin Dunleavy
Jun 8, 2026 3:12pm
FDA signs off on pediatric use of Pfizer's hemophilia treatment
Jun 8, 2026 10:32am
At ASCO, China biotech industry cements its coming of age
Jun 3, 2026 8:50am
ASCO: Pfizer one-ups J&J in prostate cancer
May 30, 2026 8:00am
AbbVie, GSK race up patient reputation leaderboard in the UK
May 22, 2026 9:16am
AZ’s Imfinzi gains ground on Keytruda in bladder cancer race
May 14, 2026 11:52am